ArticleJournal of the Endocrine Society2026

Moderate- versus high-activity radioactive iodine in intermediate-risk papillary thyroid cancer: a Canadian cohort study.

Mohammad Jay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.